Syntel, Inc. (SYNT) Tops Q3 EPS by 8c; Boosts FY14 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Weakness in Healthcare is Buying Opportunity for Syntel (SYNT) - Noble Financial
October 17, 2014 11:19 AM EDTNoble Financial maintains Syntel, Inc. (Nasdaq: SYNT) at Buy with a price target of $112 following Q3 results reported earlier this week.
Analyst Vincent Colicchio noted the following key points:
Reported third quarter 2014 EPS of $1.47, which exceeded our forecast and street consensus... More